Investing Profile

Ohad Hammer

InvestorVCScout

Partner at Pontifax Venture Capital

Your Intro Paths to Ohad Hammer

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Ohad Hammer on

Current Investing Position

Investment Range

$10.0M - $50.0M

Sweet Spot

$25.0M

Investments On Record

Ohad Hammer is on these Sector & Stage Rankings

Ohad Hammer's Investments On Record (10)

Company	StageDateRound Size	Total Raised
Adcytherix	Series AOct 2025$120M SeedJun 2024$32M	$150M
Co-investors: Ran Nussbaum (Pontifax Venture Capital), Iyona Rajkomar (Pontifax Venture Capital), Sofia Ioannidou (Andera Partners)
Step Pharma	Series COct 2025$44M Series BMar 2021$41M Series ANov 2017$17M	$110M
Co-investors: Vanessa Malier (Kurma Partners)
ADCendo	Series BNov 2024$140M Series AMay 2024$17M Series AApr 2023$34M	$250M
Co-investors: Reza Halse (RA Capital), Marten Steen (HealthCap), Joël Jean-Mairet (Ysios Capital), Iyona Rajkomar (Pontifax Venture Capital)
Eliem Therapeutics	Post Ipo EquityApr 2024$120M	$260M
Co-investors: Andrew Levin (RA Capital), Liam Ratcliffe (Access Biotechnology)
AgomAb Therapeutics	Series COct 2023$100M Series BMar 2021$74M Series AApr 2019$24M	$200M
Co-investors: Colleen Cuffaro (Canaan Partners), Felice Verduyn - van Weegen (EQT Life Sciences), Iyona Rajkomar (Pontifax Venture Capital)
Precirix	Series BMar 2022$88M Series ANov 2018$42M	$130M
Co-investors: Jasper Bos (Forbion), Marten Steen (HealthCap), Simone Botti (INKEF Capital)
Anaveon	Series BDec 2021$120M	$160M
Co-investors: Florian Müllershausen (Novartis Venture Fund), Jasper Bos (Forbion), Denis Patrick (Pfizer Venture Investments)
Emergence Therapeutics	Series ADec 2021$98M	$98M
Co-investors: Anke Cassing (High-Tech Gründerfonds), Thierry Laugel (Kurma Partners)